Cargando…
SP, CGRP changes in pyridoxine induced neuropathic dogs with nerve growth factor gene therapy
BACKGROUND: Nerve growth factor (NGF) is known not only as a major factor for neuronal plasticity but also as a pain stimulator. Although there have been several trials with NGF for its application in the regeneration or protection of the nervous system, the pain induced by NGF remains a challenge t...
Autores principales: | Kang, Joo-Yeon, Yoo, Dae Young, Lee, Kwon-Young, Im, Wooseok, Kim, Manho, Choi, Jung Hoon, Youn, Hwa-Young, Kim, Sae Hoon, Hwang, In Koo, Chung, Jin-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700743/ https://www.ncbi.nlm.nih.gov/pubmed/26728069 http://dx.doi.org/10.1186/s12868-015-0236-5 |
Ejemplares similares
-
Pyridoxine induced neuropathy by subcutaneous administration in dogs
por: Chung, Jin-Young, et al.
Publicado: (2008) -
In vitro and in vivo gene therapy with CMV vector-mediated presumed dog β-nerve growth factor in pyridoxine-induced neuropathy dogs
por: Chung, Jin-Young, et al.
Publicado: (2008) -
Beta-nerve growth factor gene therapy alleviates pyridoxine-induced neuropathic damage by increasing doublecortin and tyrosine kinase A in the dorsal root ganglion
por: Cho, Hyun-Kee, et al.
Publicado: (2019) -
Neuropathological changes in dorsal root ganglia induced by pyridoxine in dogs
por: Yun, Sumin, et al.
Publicado: (2020) -
Suitability of autologous serum for expanding rabbit adipose-derived stem cell populations
por: Bahn, Jae-Jun, et al.
Publicado: (2012)